Shanghai MicroPort MedBot Completes Successful H Share Placement

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) just unveiled an update.

Shanghai MicroPort MedBot (Group) Co., Ltd. announced the successful completion of placing 25,136,500 new H shares at HK$15.5 per share, raising approximately HK$382.33 million in net proceeds. The funds will be used primarily for the development and commercialization of the company’s core business products, both locally and overseas, as well as for research and development to enhance product performance. Additionally, 30% of the proceeds will be allocated to replenishing working capital and general corporate purposes, with an expected utilization by the end of 2027. The placing did not result in any new substantial shareholders.

The most recent analyst rating on (HK:2252) stock is a Buy with a HK$9.50 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.

More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H

Shanghai MicroPort MedBot (Group) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, focusing on the development and commercialization of medical robotic systems. The company is involved in the research and development of advanced medical technologies aimed at enhancing product performance and optimizing upgrades.

Average Trading Volume: 10,649,464

Technical Sentiment Signal: Buy

Current Market Cap: HK$15.96B

Learn more about 2252 stock on TipRanks’ Stock Analysis page.